Lawrence G. Hamel
2016
In 2016, Lawrence G. Hamel earned a total compensation of $623.5K as Chief Development Officer at AcelRx Pharmaceuticals, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $113,393 |
|---|---|
| Option Awards | $165,495 |
| Salary | $334,000 |
| Other | $10,600 |
| Total | $623,488 |
Hamel received $334K in salary, accounting for 54% of the total pay in 2016.
Hamel also received $113.4K in non-equity incentive plan, $165.5K in option awards and $10.6K in other compensation.
Rankings
In 2016, Lawrence G. Hamel's compensation ranked 10,388th out of 14,075 executives tracked by ExecPay. In other words, Hamel earned more than 26.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,388 out of 14,075 | 26th |
Division Manufacturing | 4,011 out of 5,486 | 27th |
Major group Chemicals And Allied Products | 1,417 out of 1,900 | 25th |
Industry group Drugs | 1,136 out of 1,543 | 26th |
Industry Pharmaceutical Preparations | 887 out of 1,173 | 24th |
Source: SEC filing on April 28, 2017.
Hamel's colleagues
We found five more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2016.
2016
Howard Rosen
AcelRx Pharmaceuticals
Chief Executive Officer
2016
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
2016
Timothy Morris
AcelRx Pharmaceuticals
Chief Financial Officer
2016
Jane Wright-Mitchell
AcelRx Pharmaceuticals
Chief Legal Officer
2016
Badri Dasu
AcelRx Pharmaceuticals